Pilocarpine
Pilocarpine is a cholinergic agent used as eye drops to treat glaucoma and presbyopia, and as oral tablets to treat dry mouth caused by head and neck radiation or Sjögren's syndrome.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 13 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Pilocarpine: Patient Information Guide
A plain-language walkthrough of Pilocarpine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Pilocarpine is used across two very different forms — eye drops and oral tablets — for distinct medical conditions.
- Pilocarpine Hydrochloride Ophthalmic solution (eye drops) lowers elevated pressure inside the eye in people with open-angle glaucoma or ocular hypertension
- Pilocarpine Hydrochloride Ophthalmic solution (eye drops) is used to manage acute angle-closure glaucoma
- Pilocarpine Hydrochloride Ophthalmic solution (eye drops) prevents pressure spikes after laser eye surgery
- Pilocarpine Hydrochloride Ophthalmic solution (eye drops) is used to induce miosis (pupil constriction) when clinically needed
- Vuity eye drops are approved to treat presbyopia (age-related loss of near-vision focus) in adults
- Qlosi eye drops are approved to treat presbyopia in adults
- Pilocarpine Hydrochloride Ophthalmic solution 1.25% is approved to treat presbyopia in adults
- Pilocarpine hydrochloride tablets (including Salagen) treat dry mouth from salivary gland damage caused by radiation therapy for head and neck cancer
- Pilocarpine hydrochloride tablets (including Salagen) treat dry mouth in people with Sjögren's syndrome
⚙️How it works▾
Pilocarpine is a cholinergic agent — it binds to and activates muscarinic receptors, which are the body's chemical on-switches for secretion and smooth muscle activity. In the eye, activating these receptors constricts the pupil and improves the drainage of fluid, which lowers pressure inside the eye; it also helps the eye's lens adjust focus, which is useful in presbyopia. When taken by mouth, it stimulates the salivary glands directly, increasing the amount of saliva produced and relieving the discomfort of a dry mouth.
Because these receptors are found throughout the body, pilocarpine can also stimulate sweat glands, the digestive tract, and the airways — which is why side effects like sweating, nausea, and breathing changes can occur.
💊How it's taken▾
Pilocarpine comes in two very different forms with different schedules, so the route matters a lot.
- Eye drops for glaucoma: typically one drop in the eye(s) up to four times daily — frequency depends on how severe the pressure elevation is
- Eye drops for presbyopia (Vuity): one drop in each eye once daily, with an optional second dose 3–6 hours later
- Eye drops for presbyopia (Qlosi): one drop in each eye, which may be repeated once after 2–3 hours, up to twice daily
- Tablets for dry mouth: taken multiple times a day — your prescriber will set the schedule; high-fat meals can slow how quickly the tablet is absorbed
If you have moderate liver disease, the oral tablet dose will start lower. Severe liver impairment is a reason to avoid the tablets altogether. Always follow your prescriber's exact directions.
🤒Side effects — in detail▾
The most common side effects are linked to pilocarpine's action on the body's secretory glands and smooth muscles.
- Sweating (very common with oral tablets, especially at higher doses)
- Nausea
- Runny nose
- Diarrhea
- Chills
- Blurred vision or reduced night vision (eye drops)
- Reduced depth perception (eye drops)
Contact your doctor or seek urgent care if you develop wheezing or difficulty breathing, a very fast or slow heartbeat, or any signs of fluid in the lungs such as sudden shortness of breath — these are signs of a more serious reaction that needs prompt attention.
⚠️Warnings & precautions▾
- Heart disease: Pilocarpine can cause unpredictable changes in blood pressure and heart rate — both increases and decreases have been reported. People with significant cardiovascular disease need close monitoring.
- Lung and airway problems: Pilocarpine tightens bronchial smooth muscle and increases airway secretions. It is contraindicated in uncontrolled asthma and should be used very carefully in people with controlled asthma, chronic bronchitis, or COPD.
- Vision impairment from eye drops: The drops can blur vision and reduce depth perception, especially at night or in low light. Do not drive or operate machinery in reduced lighting if your vision is affected.
- Pulmonary edema (fluid in the lungs): This has been reported as a serious complication when high doses of pilocarpine eye drops are used for acute angle-closure glaucoma.
- Liver disease: Moderate liver impairment slows the body's clearance of oral pilocarpine, increasing exposure. A lower starting dose is required. Severe liver impairment: tablets are not recommended.
🔀What it interacts with▾
Pilocarpine can interact with several types of medications — tell your doctor and pharmacist about everything you take.
- Beta-blockers (e.g., metoprolol, atenolol): combining with pilocarpine may cause heart conduction problems or rhythm disturbances
- Other parasympathomimetic drugs (drugs that mimic the same nerve signals): effects add together and increase the chance of side effects like sweating, nausea, and slow heart rate
- Anticholinergic drugs (e.g., atropine, inhaled ipratropium): pilocarpine works against these, and may reduce how well they work — this is important if you rely on them for conditions like COPD
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take pilocarpine if you have uncontrolled asthma — it can dangerously tighten the airways
- Do not take it if you are allergic to pilocarpine
- Oral pilocarpine tablets should not be used when miosis (pupil constriction) would be harmful — for example, in acute iritis or narrow-angle glaucoma
- Tell your doctor if you have heart disease — pilocarpine can affect heart rate and blood pressure
- Tell your doctor if you have controlled asthma, chronic bronchitis, or COPD — use is possible but requires close supervision
- Tell your doctor if you have liver problems: moderate impairment requires a dose reduction; severe impairment means tablets are not recommended
- Older adults, especially elderly women, may absorb more of the oral tablet — discuss dosing with your prescriber
- Kidney disease does not appear to significantly change how the body handles oral pilocarpine, based on available data
🚑If you take too much▾
A pilocarpine overdose is a medical emergency. Fatal overdoses have been reported in hospitalized patients who received very large amounts. If you suspect an overdose, call emergency services or poison control immediately.
Medical treatment for overdose typically involves atropine (given by injection) to counteract pilocarpine's effects, along with supportive care to maintain breathing and circulation. Epinephrine may also be used if there is severe cardiovascular collapse or severe bronchospasm.
📡Pharmacodynamics — effects in the body▾
Pilocarpine stimulates the body's exocrine glands — including the salivary, sweat, lacrimal (tear), and digestive glands — causing them to increase secretions. In the eye, it constricts the pupil (miosis), causes the focusing muscle to tighten (spasm of accommodation), and lowers intraocular pressure after an initial brief rise. It also increases smooth muscle tone in the digestive tract, urinary tract, and airways, and can produce complex and sometimes unpredictable effects on the cardiovascular system, including both drops and rises in blood pressure, and both slowing and speeding of the heart rate.
🔬Pharmacokinetics — how your body processes it▾
When taken by mouth, pilocarpine is absorbed relatively quickly — saliva flow increases within about 20 minutes and peaks around 1 hour, lasting 3 to 5 hours. The drug is broken down at nerve junctions and in the blood, and is excreted through the urine. It has a short half-life (the time for blood levels to drop by half), typically less than 1.5 hours at standard doses. People with moderate liver disease clear the drug more slowly, roughly doubling their exposure — which is why a lower dose is used. Kidney disease does not significantly change how the drug behaves. Elderly women tend to have higher blood levels than elderly men or younger adults at the same dose.
📦How to store it▾
Store at 20 o to 25 o C (68 o to 77 o F) .
📄 Written from Pilocarpine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Pilocarpine
40 supplements and herbal products have documented interactions with Pilocarpine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 28
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Pilocarpine — the kind of thing our pharmacy team would talk through with you at the counter.
I have two different conditions — can the same pilocarpine drop treat both glaucoma and my dry eyes? ▾
I started the tablets for dry mouth — when will I notice a difference? ▾
The eye drops are making my vision blurry — is that normal, and should I be worried? ▾
I take a beta-blocker for my heart. Is it safe to use pilocarpine? ▾
I have asthma — is pilocarpine safe for me? ▾
What should I do if I accidentally take too much of the tablet? ▾
Is Pilocarpine available over the counter? ▾
When was Pilocarpine first available? ▾
Who makes Pilocarpine? ▾
💬 Answers drafted from Pilocarpine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Pilocarpine comes
Pilocarpine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Salagen tablets are used to treat dry mouth caused by salivary gland damage from radiation therapy for head and neck cancer
- Salagen tablets are used to treat dry mouth in patients with Sjögren's syndrome
- Pilocarpine Hydrochloride tablets are used to relieve dry mouth from radiation-related salivary gland damage or Sjögren's syndrome
- Salagen and pilocarpine hydrochloride tablets are taken by mouth multiple times daily — your prescriber will set the exact schedule based on your condition
- For head and neck cancer dry mouth: tablets are typically taken three times a day; at least 12 weeks of continuous use may be needed to judge effectiveness
- For Sjögren's syndrome: tablets are typically taken four times a day; improvement may be seen by 6 weeks
- If you have moderate liver impairment, your starting dose will be lower — do not adjust your dose on your own
Eye drops
How this form is used
- Pilocarpine Hydrochloride Ophthalmic solution is used to lower elevated eye pressure in open-angle glaucoma or ocular hypertension
- Pilocarpine Hydrochloride Ophthalmic solution is used to manage acute angle-closure glaucoma and to prevent pressure spikes after laser eye surgery
- Vuity is approved to treat presbyopia (age-related difficulty focusing up close) in adults
- Qlosi is approved to treat presbyopia in adults
- Pilocarpine Hydrochloride Ophthalmic solution (for glaucoma): instill one drop in the affected eye(s) up to four times daily as directed
- Vuity (for presbyopia): instill one drop in each eye once daily; a second drop may be added 3–6 hours later if needed
- Qlosi (for presbyopia): instill one drop in each eye; may be repeated once after 2–3 hours, up to twice daily
- If using more than one eye drop product, wait at least 5 minutes between each one
📊 Pilocarpine across the U.S. market
How Pilocarpine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Pilocarpine is used
A general measure of how commonly Pilocarpine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Pilocarpine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Pilocarpine prescribed? Of the 1,596 medications we measure, Pilocarpine ranks #652 by Medicaid prescriptions — more than 59% of them.
Utilization by Pilocarpine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
pilocarpine hydrochloride 5 MG Oral Tablet Most dispensed
Summed across the 5 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1000913
pilocarpine hydrochloride 7.5 MG Oral Tablet
Summed across the 2 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1001004
pilocarpine hydrochloride 10 MG/ML Ophthalmic Solution
Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1000647
pilocarpine hydrochloride 20 MG/ML Ophthalmic Solution
Summed across the 3 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1000862
pilocarpine hydrochloride 12.5 MG/ML Ophthalmic Solution
Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2584552
pilocarpine hydrochloride 40 MG/ML Ophthalmic Solution
Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1000897
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Pilocarpine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 18 of 55 listed Pilocarpine NDCs with Medicaid activity.
🔍 Compare Pilocarpine products
A representative set of FDA-listed product records for Pilocarpine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 12.5 mg/mL | Ophthalmic | AbbVie Inc. × 3 listings | NDA | View NDC → |
| 10 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 20 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 40 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 10 mg/mL | Ophthalmic | Alcon Laboratories, Inc. | NDA | View NDC → |
| 20 mg/mL | Ophthalmic | Alcon Laboratories, Inc. | NDA | View NDC → |
| 10 mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC × 3 listings | ANDA | View NDC → |
| 12.5 mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| 20 mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC × 3 listings | ANDA | View NDC → |
| 40 mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Ophthalmic | Orasis Pharmaceuticals, Inc. | NDA | View NDC → |
| 10 mg/mL | Ophthalmic | Sandoz Inc × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 20 mg/mL | Ophthalmic | Sandoz Inc × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 40 mg/mL | Ophthalmic | Sandoz Inc × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 10 mg/mL | Ophthalmic | Somerset Therapeutics, LLC × 3 listings | ANDA | View NDC → |
| 20 mg/mL | Ophthalmic | Somerset Therapeutics, LLC × 3 listings | ANDA | View NDC → |
| 40 mg/mL | Ophthalmic | Somerset Therapeutics, LLC × 3 listings | ANDA | View NDC → |
| 💊Tablet | ||||
| 5 mg | Oral | Actavis Pharma, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 7.5 mg | Oral | Actavis Pharma, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 5 mg | Oral | Advanz Pharma (US) Corp. | NDA | View NDC → |
| 7.5 mg | Oral | Advanz Pharma (US) Corp. | NDA | View NDC → |
| 5 mg | Oral | American Health Packaging × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 5 mg | Oral | Amici Pharmaceuticals Llc | ANDA | View NDC → |
| 5 mg | Oral | Amneal Pharmaceuticals NY LLC × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Amneal Pharmaceuticals of New York LLC | ANDA | Find on DailyMed ↗ |
| 7.5 mg | Oral | Amneal Pharmaceuticals of New York LLC | ANDA | Find on DailyMed ↗ |
| 5 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Bryant Ranch Prepack × 14 listings | ANDA | View NDC → |
| 5 mg | Oral | Concordia Pharmaceuticals Inc. | NDA | View NDC → |
| 7.5 mg | Oral | Concordia Pharmaceuticals Inc. | NDA | View NDC → |
| 5 mg | Oral | Eisai Inc. | NDA | View NDC → |
| 5 mg | Oral | Lannett Company, Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Lannett Company, Inc. × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 7.5 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 5 mg | Oral | Padagis US LLC | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Anidro do Brasil Extracoes S.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | C-squared Pharma Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | C-squared Pharma Sarl × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg | — | Catalent Micron Technologies, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Spera Nexus, Inc. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Zhejiang Ausun Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zhejiang Ausun Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 87 of 87 products — FDA National Drug Code Directory. See every product, package size and price: browse all 87 Pilocarpine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Pilocarpine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Pilocarpine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Pilocarpine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 8328 3 dose forms · 15 strengths
-
Dose form (SCDF) Ophthalmic Gel RxCUI 373453No current FDA listingClinical drug / strength (SCD) hydrochloride 0.04 MG/MGRxCUI 1000638 -
Dose form (SCDF) Ophthalmic Solution RxCUI 373454In current FDA listingsClinical drug / strength (SCD) hydrochloride 1 MG/MLRxCUI 1001402hydrochloride 10 MG/MLRxCUI 1000647hydrochloride 100 MG/MLRxCUI 1000664hydrochloride 12.5 MG/MLRxCUI 2584552hydrochloride 2.5 MG/MLRxCUI 1000668hydrochloride 20 MG/MLRxCUI 1000862hydrochloride 30 MG/MLRxCUI 1000884hydrochloride 4 MG/MLRxCUI 2695439hydrochloride 40 MG/MLRxCUI 1000897hydrochloride 5 MG/MLRxCUI 1000917hydrochloride 60 MG/MLRxCUI 1000939hydrochloride 80 MG/MLRxCUI 1001014 -
Dose form (SCDF) Oral Tablet RxCUI 374421In current FDA listings
Look up RxCUI 8328 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Pilocarpine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 3 more on the FDA NDC directory.
RxNorm drug class
Pilocarpine belongs to the Cholinergic Receptor Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 13 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. American Health Packaging is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.